Fischer Medical Ventures Stock Split to Re 1 Face Value Effective Tomorrow

Mumbai, September 11, 2025: Fischer Medical Ventures Limited (NSE: FISCHER) has announced that it will undergo a stock split under which the face value of its equity shares will be subdivided from ₹10 per share to Re 1 per share. The co͏mp͏any has set both ͏the Ex-Split ͏Date and Re͏cord Date͏ to ensure smoo͏th i͏mplementation of th͏e s͏pli͏t.

Market Snapshot

As of September 11, 2025, 12:33 p.m., shares of Fischer Medical Ventures Limited were trading at ₹1,140.60, a fall of 20.30, decreasing by 1.75%, as compared to its previous close of ₹1,160.90. Despite the fall in the price, the shares have been trading between a healthy intraday high and low of ₹1,194.40 and ₹1,134.70 so far. The trading volumes have reached 0.26 lakhs, while the traded value and total market cap stood at ₹3.04 Cr. and ₹7,396.97 Cr. respectively.

What the Stock Split Means

A stock split is a financial move under which the number of outstanding shares is increased by proportionately reducing the face value of the shares. As the split is done proportionately, it does not change the company’s overall market capitalization.

In this case, every one share of ₹10 face value will be split into ten shares of Re 1 face value. This means that if an investor currently holds 100 shares of ₹10 face value, post-split, they will have 1,000 shares of Re 1 face value. So, as the total value of the holding remains unchanged, the price per share will adjust proportionately.

Impact on Share Price and Liquidity

Share split is a strategic move made by a company as it has a significant impact on both share price and the liquidity of the company:

• Post split, there will be a price adjustment as the market price of Fischer Medical’s shares might reduce in proportion to the split ratio (1:10). If the stock trades at ₹1,000 today, it would adjust to around ₹100 after the split.
• The stock of the company will have a liquidity boost, as with a lower per-share price, the stock will become more affordable for retail investors. This will potentially increase trading volumes and liquidity in the counter.
• However, the split will not impact the company’s market capitalisation, which will remain unchanged post the split. It is because the split does not affect earnings or the intrinsic value of the business.

Outlook

Stock splits are usually perceived as a shareholder-friendly move as they are aimed at improving accessibility and participation in the stock. For Fischer Medical Ventures, the split could improve its market penetration, especially in the retail investor base. The move is also expected to enhance the company’s trading activity. While the company enjoys a better share price and liquidity, investors should keep an eye out for the company’s business performance as its long-term valuations will continue to depend on it.

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations